Total Payments
$2,762
2024 Payments
$296.27
Companies
25
Transactions
182
Medicare Patients
1,392
Medicare Billing
$617,091
Payment Breakdown by Category
Food & Beverage$2,762 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,762 | 182 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $599.00 | 44 | $0 (2022) |
| ABBVIE INC. | $521.57 | 48 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $426.49 | 29 | $0 (2020) |
| Amgen Inc. | $151.75 | 4 | $0 (2022) |
| Allergan, Inc. | $146.91 | 7 | $0 (2022) |
| PFIZER INC. | $102.47 | 7 | $0 (2024) |
| Medtronic USA, Inc. | $90.77 | 1 | $0 (2017) |
| Supernus Pharmaceuticals, Inc. | $86.57 | 7 | $0 (2020) |
| ACADIA Pharmaceuticals Inc | $77.62 | 1 | $0 (2022) |
| EMD Serono, Inc. | $64.78 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $296.27 | 26 | ABBVIE INC. ($239.98) |
| 2023 | $267.34 | 23 | AbbVie Inc. ($163.87) |
| 2022 | $385.65 | 17 | ACADIA Pharmaceuticals Inc ($77.62) |
| 2021 | $336.72 | 31 | Novartis Pharmaceuticals Corporation ($204.08) |
| 2020 | $161.84 | 9 | Allergan, Inc. ($72.10) |
| 2019 | $249.73 | 16 | Novartis Pharmaceuticals Corporation ($71.57) |
| 2018 | $305.87 | 18 | Amgen Inc. ($80.70) |
| 2017 | $759.03 | 42 | Sunovion Pharmaceuticals Inc. ($393.51) |
All Payment Transactions
182 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $10.66 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/11/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/23/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.19 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/10/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $10.47 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.09 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.09 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: PAIN | ||||||
| 07/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.92 | General |
| Category: NEUROSCIENCE | ||||||
| 06/19/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: Immunology | ||||||
| 06/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $4.97 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $0.53 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/28/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: PAIN | ||||||
| 05/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.81 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: NEUROSCIENCE | ||||||
| 05/07/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $6.41 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.58 | General |
| Category: NEUROSCIENCE | ||||||
| 03/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $8.84 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/21/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $3.79 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 223 | 252 | $57,557 | $20,883 |
| 2022 | 6 | 307 | 347 | $65,870 | $24,616 |
| 2021 | 11 | 491 | 11,372 | $1.9M | $543,043 |
| 2020 | 7 | 371 | 422 | $76,330 | $28,550 |
Total Patients
1,392
Total Services
12,393
Medicare Billing
$617,091
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 86 | 99 | $11,880 | $5,481 | 46.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 33 | 35 | $9,800 | $3,398 | 34.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 23 | 24 | $9,120 | $3,116 | 34.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $5,415 | $2,240 | 41.4% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 13 | 21 | $9,912 | $1,796 | 18.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $3,850 | $1,793 | 46.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 20 | $3,325 | $1,696 | 51.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 19 | 23 | $4,255 | $1,361 | 32.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 129 | 158 | $18,960 | $8,915 | 47.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 54 | 54 | $15,390 | $4,775 | 31.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 43 | 44 | $12,320 | $4,410 | 35.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 20 | 20 | $7,600 | $2,986 | 39.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 34 | 40 | $7,400 | $2,047 | 27.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 12 | $1,920 | $873.21 | 45.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 16 | 19 | $2,280 | $610.04 | 26.8% |
| J2350 | Injection, ocrelizumab, 1 mg | Office | 2021 | 11 | 10,800 | $1.8M | $499,558 | 28.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 167 | 196 | $23,520 | $11,731 | 49.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 74 | 76 | $28,880 | $11,414 | 39.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 91 | 91 | $25,935 | $9,909 | 38.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 46 | 60 | $11,100 | $3,211 | 28.9% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 13 | 20 | $9,520 | $1,746 | 18.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 11 | 11 | $3,850 | $1,545 | 40.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 27 | 33 | $3,960 | $1,507 | 38.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 16 | $3,185 | $1,506 | 47.3% |
| 96415 | Infusion of chemotherapy into a vein | Office | 2021 | 12 | 31 | $3,162 | $612.16 | 19.4% |
About Dr. Christopher Rocco, MD
Dr. Christopher Rocco, MD is a Neurology healthcare provider based in Anderson, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508957952.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Rocco, MD has received a total of $2,762 in payments from pharmaceutical and medical device companies, with $296.27 received in 2024. These payments were reported across 182 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,762).
As a Medicare-enrolled provider, Rocco has provided services to 1,392 Medicare beneficiaries, totaling 12,393 services with total Medicare billing of $617,091. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Anderson, IN
- Active Since 09/28/2006
- Last Updated 10/22/2019
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1508957952
Products in Payments
- APTIOM (Drug) $450.73
- BOTOX (Biological) $308.80
- KESIMPTA (Drug) $282.16
- GILENYA (Drug) $154.36
- Aimovig (Biological) $151.75
- QULIPTA (Drug) $122.34
- UBRELVY (Drug) $118.62
- RESTORE (Device) $90.77
- DUOPA (Drug) $82.02
- MAYZENT (Drug) $78.05
- NUPLAZID (Drug) $77.62
- TROKENDI XR (Drug) $62.68
- LYRICA (Drug) $52.71
- BRIUMVI (Drug) $45.86
- Rebif (Biological) $38.61
- iFuse Implant (Device) $38.08
- NURTEC ODT (Drug) $33.34
- Radicava (Drug) $31.48
- AUBAGIO (Drug) $31.40
- AIMOVIG (Biological) $28.29
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Anderson
Marc Cohen, Md, MD
Neurology — Payments: $15,277
Neurology $15,277
Caroline Stevens, Do, DO
Neurology — Payments: $10,708
Neurology $10,708
Dr. Judi Knowles, M.d, M.D
Neurology — Payments: $8,969
Neurology $8,969
Mr. Dixon Cunningham, Md, MD
Neurology — Payments: $7,806
Neurology $7,806
Dr. Paul Brill, M.d, M.D
Neurology — Payments: $6,757
Neurology $6,757
Kumar Patel, M.d, M.D
Neurology — Payments: $387.35
Neurology $387.35